Prem Lachman Buys Shares of OPK
Prem Lachman purchased 30,000 shares of OPK on June 18, 2026.
Key Points
- Prem Lachman bought 30,000 shares of OPK on June 18, 2026, adding to his holdings.
- Shares of OPK traded at $1.43 on Tuesday, with institutional investors like BlackRock increasing their stakes.
- Analysts like Barrington Research maintain a buy rating, setting a price target of $1.50.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Prem Lachman bought 30,000 shares of OPK on June 18, 2026. This insider transaction was not part of a pre-arranged trading plan. Shares of OPK traded at about $1.43 on Tuesday.
Other Institutional Activity in OPK
Several institutional investors have been active in OPK recently. BlackRock, Inc. increased its holdings by 1,380,193 shares, bringing its total to 36,232,223 shares valued at approximately $41.3 million, a 4.0% increase. Vanguard Portfolio Management LLC opened a new position with 14,769,719 shares worth about $16.8 million. Similarly, Vanguard Capital Management LLC also initiated a stake, acquiring 14,499,164 shares valued at roughly $16.5 million. Geode Capital Management, LLC added 240,183 shares, ending with 11,301,501 shares valued at $12.9 million, marking a 2.2% increase. State Street Corp grew its position by 549,615 shares, totaling 9,501,377 shares worth around $10.8 million, a 6.1% rise.
Insider Buying and Selling at OPKO Health, Inc.
On June 18, 2026, several insiders purchased shares of OPK. Richard Pfenniger Jr. bought 60,000 shares, while John Paganelli and Alice Lin-Tsing Yu each acquired 30,000 shares. Subbarao Uppaluri made a larger purchase of 80,000 shares. Roger Medel MD and Prem Lachman also bought 30,000 shares each. These transactions were not made under Rule 10b5-1 plans.
Analysts Set New Price Targets
On March 2, 2026, Barrington Research maintained its buy rating on OPK, setting a price target of $1.50. Jefferies had previously downgraded the stock to hold with a target of $1.60 on October 31, 2025. Overall, analysts maintain a positive outlook with a consensus buy recommendation, and the average target price is around $1.50.
Bottom Line
Prem Lachman's purchase of OPK shares adds to the recent insider buying activity, suggesting confidence in the company's prospects. Institutional investors are also showing interest, with major funds like BlackRock increasing their stakes. Analysts continue to support the stock with buy ratings and price targets around $1.50, indicating a generally positive sentiment. As always, these insights are based on past filings and may not reflect the current market conditions.
Get OPKO Health, Inc. alerts
New 13F filings, insider trades, and analyst moves on $OPK, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.